+122,153.5%
KLAC vs CVS
+1,777.2%
+120,376.3%
-83.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | CVS | Excess | Alpha |
|---|---|---|---|---|
| 1D | -5.3% | -0.9% | -4.5% | -5.1% |
| 7D | -4.8% | +3.9% | -8.7% | -5.8% |
| 30D | -13.0% | -3.4% | -9.6% | -12.4% |
| 3M | -29.1% | -8.2% | -21.0% | -27.8% |
| 6M | -19.9% | -6.4% | -13.5% | -19.1% |
| YTD | +19.1% | +15.1% | +4.0% | +11.9% |
| 1Y | +27.8% | +17.4% | +10.4% | +19.2% |
| 3Y | +170.0% | +45.3% | +124.6% | +125.9% |
| 5Y | +256.7% | +12.7% | +244.0% | +220.2% |
| 10Y | +2,058.0% | +62.1% | +1,995.9% | +1,564.4% |
| All | +122,153.5% | +1,777.2% | +120,376.3% | +40,248.6% |
Cumulative growth
Daily Returns
Daily percentage return beside CVS.
Daily Out/Under-Performance
Portfolio return minus CVS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CVS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded CVS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling